Oncology News

A new test could predict which women have an aggressive form of breast cancer in the milk ducts (DCIS ) and spare other women from unnecessary radiotherapy, according to research1 published in the British Journal of Cancer today (Wednesday). The test looks at and compares the unique features of DCIS cancer cells...
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies. Moreover, asbestos exposure increases the risk of lung cancer among smokers...
Oncimmune LLC, provider of EarlyCDT-Lung, a simple physician-ordered blood test that aids physicians in the risk assessment and early detection of lung cancer in high-risk patients, most notably long-term smokers or former smokers, today announced that the test is now commercially available in Canada after receiving strong interest from Canadian physicians at the American Colle...
As the scientific evidence mounts, more federal agencies and state governments are taking action to educate and protect Americans against the serious risks of indoor tanning...
A new way to deliver cancer drugs using gas bubbles and sound waves is to be developed at the University of Leeds. The project will enable highly toxic drugs to be delivered in small doses directly to tumours, where their toxicity can safely be put to good use. If successful, the technique could easily be adapted for other diseases...
Vietnam War-era veterans exposed to Agent Orange appear to have significantly more Graves' disease, a thyroid disorder, than veterans with no exposure, a new study by endocrinologists at the University at Buffalo has shown...
Researchers have identified cells in the immune system that react to the stomach ulcer bacterium Helicobacter pylori, one of the risk factors for the development of stomach cancer. This discovery could lead to faster diagnosis and treatment as well as a better prognosis for patients with stomach cancer, reveals a thesis from the University of Gothenburg, Sweden...
In draft guidance, published today, NICE has been unable to recommend imatinib (Glivec) at doses of 600 or 800 mg/day for people with unresectable and/or metastatic gastrointestinal stromal tumours (GIST) whose disease has progressed after treatment with 400 mg/day imatinib...
Cancer occurs when human cells move and multiply inappropriately. Within cells, a process called phosphorylation serves as an on/off switch for a number of cellular processes that can be involved in cancer, including metabolism, transcription, configuration, movement, cell death and differentiation...